Clinical trial
STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of…
NCT00252824 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00252824 |
|---|---|
| Title | STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma |
| Official title | A Comparison of the Efficacy of Symbicort® Single Inhaler Therapy (Symbicort Turbuhaler® 160/4.5 mg 1 Inhalation b.i.d. Plus As-needed) and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults - a 26 Weeks, Randomised, Open-label, Parallel-group, Multicentre… |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Budesonide/formoterol Turbuhaler vs Conventional Best Asthma Therapy |
| Enrollment | 1,000 |
| Start date | Jul 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Nov 15, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | Chile, Croatia, Czechia, Greece, Iceland, Latvia, Lithuania, Portugal, Slovakia, Slovenia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: